JOHN M. LEONARD Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN M. LEONARD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN M. LEONARD. JOHN M. LEONARD is Director in CHIMERIX INC ($CMRX) and Director in Vitae Pharmaceuticals, Inc ($VTAE) and Director in Quintiles Transnational Holdings Inc. ($Q) and SVP, Chief Scientific Officer in AbbVie Inc. ($ABBV) and CEO in Intellia Therapeutics, Inc. ($NTLA) and EVP, R&D in Intellia Therapeutics, Inc. ($NTLA) and President and CEO in Intellia Therapeutics, Inc. ($NTLA).
Latest Insider Trading Transactions of JOHN M. LEONARD
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ABBV, CMRX, NTLA, IQV, VTAE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 19 2021 | IQV | IQVIA HOLDINGS INC ... | LEONARD JOHN M | Director | Grant | A | 0.00 | 934 | 0 | 10,678 | 9.7 K to 10.7 K (+9.59 %) |
| Apr 15 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 13.88 | 15,937 | 221,206 | 15,937 | |
| Apr 15 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 6.83 | 10,000 | 68,300 | 10,000 | |
| Apr 15 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 13.88 | 15,937 | 221,206 | 719,305 | 703.4 K to 719.3 K (+2.27 %) |
| Apr 15 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 6.83 | 10,000 | 68,300 | 703,368 | 693.4 K to 703.4 K (+1.44 %) |
| Apr 15 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 13.88 | 15,937 | 221,206 | 15,937 | |
| Apr 15 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 6.83 | 10,000 | 68,300 | 10,000 | |
| Apr 15 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 13.88 | 15,937 | 221,206 | 719,305 | 703.4 K to 719.3 K (+2.27 %) |
| Apr 15 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 6.83 | 10,000 | 68,300 | 703,368 | 693.4 K to 703.4 K (+1.44 %) |
| Apr 02 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 13.40 | 26,041 | 348,949 | 273,959 | |
| Apr 02 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 14.58 | 45,000 | 656,100 | 155,000 | |
| Apr 02 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 83.00 | 13,895 | 1,153,285 | 693,368 | 707.3 K to 693.4 K (-1.96 %) |
| Apr 02 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 13.40 | 26,041 | 348,949 | 707,263 | 681.2 K to 707.3 K (+3.82 %) |
| Apr 02 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 84.00 | 24,314 | 2,042,376 | 681,222 | 705.5 K to 681.2 K (-3.45 %) |
| Apr 02 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 14.58 | 45,000 | 656,100 | 705,536 | 660.5 K to 705.5 K (+6.81 %) |
| Mar 05 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | A | 0.00 | 31,394 | 0 | 31,394 | |
| Mar 05 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | A | 57.71 | 188,363 | 10,870,429 | 188,363 | |
| Feb 09 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 6.83 | 56,718 | 387,384 | 68,516 | |
| Feb 09 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 13.40 | 40,000 | 536,000 | 285,453 | |
| Feb 09 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 75.00 | 28,043 | 2,103,225 | 660,536 | 688.6 K to 660.5 K (-4.07 %) |
| Feb 09 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 6.83 | 56,718 | 387,384 | 688,579 | 631.9 K to 688.6 K (+8.98 %) |
| Feb 09 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 68.78 | 881 | 60,595 | 631,861 | 632.7 K to 631.9 K (-0.14 %) |
| Feb 09 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 67.86 | 14,018 | 951,261 | 632,742 | 646.8 K to 632.7 K (-2.17 %) |
| Feb 09 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 67.18 | 8,043 | 540,329 | 646,760 | 654.8 K to 646.8 K (-1.23 %) |
| Feb 09 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 13.40 | 40,000 | 536,000 | 654,803 | 614.8 K to 654.8 K (+6.51 %) |
| Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 13.88 | 67,060 | 930,793 | 17,940 | |
| Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 22.78 | 50,000 | 1,139,000 | 110,000 | |
| Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 22.78 | 60,000 | 1,366,800 | 160,000 | |
| Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 18.30 | 30,000 | 548,850 | 27,500 | |
| Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 13.88 | 10,000 | 138,800 | 85,000 | |
| Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 6.83 | 100,000 | 683,000 | 125,234 | |
| Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 73.00 | 36,858 | 2,690,634 | 614,803 | 651.7 K to 614.8 K (-5.66 %) |
| Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 13.88 | 67,060 | 930,793 | 651,661 | 584.6 K to 651.7 K (+11.47 %) |
| Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 72.00 | 30,998 | 2,231,856 | 584,601 | 615.6 K to 584.6 K (-5.04 %) |
| Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 22.78 | 50,000 | 1,139,000 | 615,599 | 565.6 K to 615.6 K (+8.84 %) |
| Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 65.04 | 5,475 | 356,094 | 565,599 | 571.1 K to 565.6 K (-0.96 %) |
| Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 64.10 | 16,640 | 1,066,624 | 571,074 | 587.7 K to 571.1 K (-2.83 %) |
| Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 63.30 | 11,100 | 702,630 | 587,714 | 598.8 K to 587.7 K (-1.85 %) |
| Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 22.78 | 60,000 | 1,366,800 | 598,814 | 538.8 K to 598.8 K (+11.14 %) |
| Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 65.03 | 3,260 | 211,998 | 538,814 | 542.1 K to 538.8 K (-0.60 %) |
| Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 64.09 | 9,432 | 604,497 | 542,074 | 551.5 K to 542.1 K (-1.71 %) |
| Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 63.29 | 6,448 | 408,094 | 551,506 | 558 K to 551.5 K (-1.16 %) |
| Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 18.30 | 30,000 | 549,000 | 557,954 | 528 K to 558 K (+5.68 %) |
| Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 65.02 | 693 | 45,059 | 527,954 | 528.6 K to 528 K (-0.13 %) |
| Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 64.16 | 3,497 | 224,368 | 528,647 | 532.1 K to 528.6 K (-0.66 %) |
| Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 63.24 | 1,709 | 108,077 | 532,144 | 533.9 K to 532.1 K (-0.32 %) |
| Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 13.88 | 10,000 | 138,800 | 533,853 | 523.9 K to 533.9 K (+1.91 %) |
| Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 65.00 | 8,827 | 573,755 | 523,853 | 532.7 K to 523.9 K (-1.66 %) |
| Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 64.13 | 26,058 | 1,671,100 | 532,680 | 558.7 K to 532.7 K (-4.66 %) |
| Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 63.32 | 16,750 | 1,060,610 | 558,738 | 575.5 K to 558.7 K (-2.91 %) |
| Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 6.83 | 100,000 | 683,000 | 575,488 | 475.5 K to 575.5 K (+21.03 %) |
| Jan 05 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 0.00 | 14,375 | 0 | 0 | |
| Jan 05 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | A | 0.00 | 14,375 | 0 | 14,375 | |
| Jan 05 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | A | 23.46 | 28,750 | 674,475 | 28,750 | |
| Jan 05 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 55.86 | 6,239 | 348,511 | 475,488 | 481.7 K to 475.5 K (-1.30 %) |
| Jan 05 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 0.00 | 14,375 | 0 | 481,727 | 467.4 K to 481.7 K (+3.08 %) |
| Nov 27 2020 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 14.58 | 20,000 | 291,600 | 200,000 | |
| Nov 27 2020 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 18.30 | 15,000 | 274,500 | 57,500 | |
| Nov 27 2020 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 39.00 | 20,000 | 780,000 | 467,352 | 487.4 K to 467.4 K (-4.10 %) |
| Nov 27 2020 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 14.58 | 20,000 | 291,600 | 487,352 | 467.4 K to 487.4 K (+4.28 %) |
| Nov 27 2020 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 14.58 | 20,000 | 291,600 | 200,000 | |
| Nov 27 2020 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 38.00 | 15,000 | 570,000 | 467,352 | 482.4 K to 467.4 K (-3.11 %) |
| Nov 27 2020 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 18.30 | 15,000 | 274,500 | 57,500 | |
| Nov 27 2020 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 18.30 | 15,000 | 274,500 | 482,352 | 467.4 K to 482.4 K (+3.21 %) |
| Nov 27 2020 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 39.00 | 20,000 | 780,000 | 467,352 | 487.4 K to 467.4 K (-4.10 %) |
| Nov 27 2020 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 14.58 | 20,000 | 291,600 | 487,352 | 467.4 K to 487.4 K (+4.28 %) |
| Nov 27 2020 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 38.00 | 15,000 | 570,000 | 467,352 | 482.4 K to 467.4 K (-3.11 %) |
| Nov 27 2020 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 18.30 | 15,000 | 274,500 | 482,352 | 467.4 K to 482.4 K (+3.21 %) |
| Nov 18 2020 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 14.58 | 20,000 | 291,600 | 220,000 | |
| Nov 18 2020 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 34.00 | 20,000 | 680,000 | 467,352 | 487.4 K to 467.4 K (-4.10 %) |
| Nov 18 2020 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 14.58 | 20,000 | 291,600 | 487,352 | 467.4 K to 487.4 K (+4.28 %) |
| Nov 06 2020 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 6.83 | 50,000 | 341,500 | 275,234 | |
| Nov 06 2020 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 26.00 | 50,000 | 1,300,000 | 467,352 | 517.4 K to 467.4 K (-9.66 %) |
| Nov 06 2020 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 6.83 | 50,000 | 341,500 | 517,352 | 467.4 K to 517.4 K (+10.70 %) |
| Oct 09 2020 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 6.83 | 5,000 | 34,150 | 325,234 | |
| Oct 09 2020 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 21.83 | 5,000 | 109,150 | 467,352 | 472.4 K to 467.4 K (-1.06 %) |
| Oct 09 2020 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 6.83 | 5,000 | 34,150 | 472,352 | 467.4 K to 472.4 K (+1.07 %) |
| Sep 03 2020 | NTLA | Intellia Therapeut ... | LEONARD JOHN M. | President and CEO | Option Exercise | M | 6.83 | 5,000 | 34,150 | 330,234 | |
| Sep 03 2020 | NTLA | Intellia Therapeut ... | LEONARD JOHN M. | President and CEO | Sell | S | 21.83 | 5,000 | 109,150 | 467,352 | 472.4 K to 467.4 K (-1.06 %) |
| Sep 03 2020 | NTLA | Intellia Therapeut ... | LEONARD JOHN M. | President and CEO | Buy | M | 6.83 | 5,000 | 34,150 | 472,352 | 467.4 K to 472.4 K (+1.07 %) |
| Aug 07 2020 | NTLA | Intellia Therapeut ... | LEONARD JOHN M. | President and CEO | Option Exercise | M | 6.83 | 5,000 | 34,150 | 335,234 | |
| Aug 07 2020 | NTLA | Intellia Therapeut ... | LEONARD JOHN M. | President and CEO | Sell | S | 21.83 | 5,000 | 109,150 | 467,352 | 472.4 K to 467.4 K (-1.06 %) |
| Aug 07 2020 | NTLA | Intellia Therapeut ... | LEONARD JOHN M. | President and CEO | Buy | M | 6.83 | 5,000 | 34,150 | 472,352 | 467.4 K to 472.4 K (+1.07 %) |
| Jun 05 2020 | NTLA | Intellia Therapeut ... | LEONARD JOHN M. | President and CEO | Option Exercise | M | 6.83 | 5,000 | 34,150 | 345,234 | |
| Jun 05 2020 | NTLA | Intellia Therapeut ... | LEONARD JOHN M. | President and CEO | Sell | S | 21.83 | 5,000 | 109,150 | 467,352 | 472.4 K to 467.4 K (-1.06 %) |
| Jun 05 2020 | NTLA | Intellia Therapeut ... | LEONARD JOHN M. | President and CEO | Buy | M | 6.83 | 5,000 | 34,150 | 472,352 | 467.4 K to 472.4 K (+1.07 %) |
| May 08 2020 | IQV | IQVIA HOLDINGS INC ... | LEONARD JOHN M. | Director | Grant | A | 0.00 | 1,492 | 0 | 9,744 | 8.3 K to 9.7 K (+18.08 %) |
| Mar 04 2020 | NTLA | Intellia Therapeut ... | LEONARD JOHN M. | President and CEO | Option Exercise | A | 13.40 | 340,000 | 4,556,000 | 340,000 | |
| Dec 26 2019 | IQV | IQVIA HOLDINGS INC ... | LEONARD JOHN M. | Director | Option Exercise | M | 64.52 | 7,000 | 451,640 | 0 | |
| Dec 26 2019 | IQV | IQVIA HOLDINGS INC ... | LEONARD JOHN M. | Director | Option Exercise | M | 64.86 | 6,600 | 428,076 | 0 | |
| Dec 26 2019 | IQV | IQVIA HOLDINGS INC ... | LEONARD JOHN M. | Director | Option Exercise | M | 64.93 | 6,600 | 428,538 | 0 | |
| Dec 26 2019 | IQV | IQVIA HOLDINGS INC ... | LEONARD JOHN M. | Director | Sell | S | 155.00 | 10,100 | 1,565,500 | 8,252 | 18.4 K to 8.3 K (-55.03 %) |
| Dec 26 2019 | IQV | IQVIA HOLDINGS INC ... | LEONARD JOHN M. | Director | Sell | S | 151.00 | 10,100 | 1,525,100 | 18,352 | 28.5 K to 18.4 K (-35.50 %) |
| Dec 26 2019 | IQV | IQVIA HOLDINGS INC ... | LEONARD JOHN M. | Director | Buy | M | 64.52 | 7,000 | 451,640 | 28,452 | 21.5 K to 28.5 K (+32.63 %) |
| Dec 26 2019 | IQV | IQVIA HOLDINGS INC ... | LEONARD JOHN M. | Director | Buy | M | 64.86 | 6,600 | 428,076 | 21,452 | 14.9 K to 21.5 K (+44.44 %) |
| Dec 26 2019 | IQV | IQVIA HOLDINGS INC ... | LEONARD JOHN M. | Director | Buy | M | 64.93 | 6,600 | 428,538 | 14,852 | 8.3 K to 14.9 K (+79.98 %) |
| May 20 2019 | IQV | IQVIA HOLDINGS INC ... | LEONARD JOHN M. | Director | Grant | A | 0.00 | 1,478 | 0 | 8,252 | 6.8 K to 8.3 K (+21.82 %) |
| Dec 20 2018 | NTLA | Intellia Therapeut ... | LEONARD JOHN M. | President and CEO | Option Exercise | A | 14.58 | 240,000 | 3,499,200 | 240,000 | |
| May 15 2018 | NTLA | Intellia Therapeut ... | LEONARD JOHN M. | President and CEO | Sell | S | 24.00 | 8,400 | 201,600 | 0 | 8.4 K to 0 (-100.00 %) |
| May 15 2018 | NTLA | Intellia Therapeut ... | LEONARD JOHN M. | President and CEO | Sell | S | 24.00 | 8,400 | 201,600 | 0 | 8.4 K to 0 (-100.00 %) |
| Jan 29 2018 | NTLA | Intellia Therapeut ... | LEONARD JOHN M. | CEO | Option Exercise | A | 22.78 | 220,000 | 5,011,600 | 220,000 | |
| Dec 14 2017 | NTLA | Intellia Therapeut ... | LEONARD JOHN M. | EVP, R&D | Option Exercise | A | 18.30 | 72,500 | 1,326,388 | 72,500 | |
| Jun 29 2017 | CMRX | CHIMERIX INC | LEONARD JOHN M. | Director | Option Exercise | A | 5.53 | 21,000 | 116,130 | 21,000 | |
| Jun 05 2017 | NTLA | Intellia Therapeut ... | LEONARD JOHN M. | EVP, R&D | Grant | A | 12.09 | 600 | 7,254 | 8,400 | 7.8 K to 8.4 K (+7.69 %) |
| Jun 05 2017 | NTLA | Intellia Therapeut ... | LEONARD JOHN M. | EVP, R&D | Grant | A | 12.06 | 7,800 | 94,068 | 7,800 | 0 to 7.8 K |
| May 25 2017 | Q | Quintiles IMS Hold ... | LEONARD JOHN M. | Director | Grant | A | 0.00 | 2,386 | 0 | 4,702 | 2.3 K to 4.7 K (+103.02 %) |
| Jan 10 2017 | NTLA | Intellia Therapeut ... | LEONARD JOHN M. | EVP, R&D | Option Exercise | A | 13.88 | 95,000 | 1,318,600 | 95,000 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | LEONARD JOHN M. | Director | Option Exercise | D | 9.62 | 10,000 | 96,200 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | LEONARD JOHN M. | Director | Option Exercise | D | 9.85 | 20,000 | 197,000 | 0 | |
| Sep 16 2016 | CMRX | CHIMERIX INC | LEONARD JOHN M. | Director | Sell | S | 5.03 | 5,000 | 25,163 | 0 | 5 K to 0 (-100.00 %) |
| Jun 28 2016 | CMRX | CHIMERIX INC | LEONARD JOHN M. | Director | Option Exercise | A | 3.73 | 9,000 | 33,570 | 9,000 | |
| May 27 2016 | VTAE | Vitae Pharmaceutic ... | LEONARD JOHN M. | Director | Option Exercise | A | 9.62 | 10,000 | 96,200 | 10,000 | |
| May 06 2016 | Q | Quintiles Transnat ... | LEONARD JOHN M. | Director | Option Exercise | A | 64.52 | 7,000 | 451,640 | 7,000 | |
| May 06 2016 | Q | Quintiles Transnat ... | LEONARD JOHN M. | Director | Grant | A | 0.00 | 775 | 0 | 2,316 | 1.5 K to 2.3 K (+50.29 %) |
| Aug 25 2015 | CMRX | CHIMERIX INC | LEONARD JOHN M. | Director | Buy | P | 47.38 | 1,000 | 47,380 | 1,000 | 0 to 1,000 |
| Jul 29 2015 | VTAE | Vitae Pharmaceutic ... | LEONARD JOHN M. | Director | Option Exercise | A | 9.85 | 20,000 | 197,000 | 20,000 | |
| Jun 24 2015 | CMRX | CHIMERIX INC | LEONARD JOHN M. | Director | Option Exercise | A | 45.15 | 9,000 | 406,350 | 9,000 | |
| May 08 2015 | Q | Quintiles Transnat ... | LEONARD JOHN M. | Director | Option Exercise | A | 64.86 | 6,600 | 428,076 | 6,600 | |
| May 08 2015 | Q | Quintiles Transnat ... | LEONARD JOHN M. | Director | Grant | A | 0.00 | 771 | 0 | 1,541 | 770 to 1.5 K (+100.13 %) |
| Mar 06 2015 | Q | Quintiles Transnat ... | LEONARD JOHN M. | Director | Option Exercise | A | 64.93 | 6,600 | 428,538 | 6,600 | |
| Mar 06 2015 | Q | Quintiles Transnat ... | LEONARD JOHN M. | Director | Grant | A | 0.00 | 770 | 0 | 770 | 0 to 770 |
| Mar 19 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Option Exercise | M | 28.86 | 46,700 | 1,347,893 | 46,700 | |
| Mar 19 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Sell | S | 38.45 | 46,700 | 1,795,615 | 107,320 | 154 K to 107.3 K (-30.32 %) |
| Mar 19 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Buy | M | 28.86 | 46,700 | 1,347,893 | 154,020 | 107.3 K to 154 K (+43.51 %) |
| Mar 12 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Sell | S | 37.50 | 23,644 | 886,650 | 107,320 | 131 K to 107.3 K (-18.05 %) |
| Mar 12 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Sell | S | 37.58 | 4,305 | 161,782 | 130,964 | 135.3 K to 131 K (-3.18 %) |
| Mar 04 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Payment of Exercise | F | 36.73 | 9,407 | 345,519 | 135,269 | 144.7 K to 135.3 K (-6.50 %) |
| Feb 21 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Option Exercise | M | 27.29 | 29,650 | 809,267 | 29,650 | |
| Feb 21 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Payment of Exercise | F | 37.58 | 25,345 | 952,465 | 148,981 | 174.3 K to 149 K (-14.54 %) |
| Feb 21 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Buy | M | 27.29 | 29,650 | 809,267 | 174,326 | 144.7 K to 174.3 K (+20.49 %) |
| Feb 19 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Option Exercise | A | 35.88 | 62,020 | 2,225,278 | 62,020 | |
| Feb 19 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Payment of Exercise | F | 37.58 | 7,982 | 299,964 | 144,676 | 152.7 K to 144.7 K (-5.23 %) |
| Feb 19 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Grant | A | 0.00 | 30,360 | 0 | 152,658 | 122.3 K to 152.7 K (+24.82 %) |
Page: 1